BioCentury
ARTICLE | Company News

Aros Applied Biotechnology, Stratagene deal

September 18, 2006 7:00 AM UTC

Aros granted STGN an exclusive option to evaluate and license patents and patent applications covering a family of gene expression predictors for bladder cancer. Financial terms were not disclosed. ...